Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

<h4>Background</h4>The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established.<h4>Methods</h4>We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older... View More